Svensson et al. reported that a tissue factor into microvesicles released from hypoxia glioblastoma induced protease-activated receptor 2 activation in endothelial cells, increased phosphorylation of ERK1/2 and enhanced cell proliferation and migration19. The gene discussed is MAPK3; the disease is glioblastoma.